⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
STOK News
Stoke Therapeutics, Inc. Common Stock
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
STOK
STOK
Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society (CNS) Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
businesswire.com
STOK
BIIB
STOK
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
businesswire.com
STOK
STOK